MX339484B - Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante. - Google Patents

Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante.

Info

Publication number
MX339484B
MX339484B MX2012003892A MX2012003892A MX339484B MX 339484 B MX339484 B MX 339484B MX 2012003892 A MX2012003892 A MX 2012003892A MX 2012003892 A MX2012003892 A MX 2012003892A MX 339484 B MX339484 B MX 339484B
Authority
MX
Mexico
Prior art keywords
agent
exacerbation
human knee
knee osteoarthritis
preventative
Prior art date
Application number
MX2012003892A
Other languages
English (en)
Other versions
MX2012003892A (es
Inventor
Tatsuhiko Kuroda
Toshinori Ishizuya
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Publication of MX2012003892A publication Critical patent/MX2012003892A/es
Publication of MX339484B publication Critical patent/MX339484B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al uso de PTH (1-34) humana, para preparar un medicamento, para prevenir y/o tratar y/o limitar la exacerbación de la osteoartritis de rodilla humana concomitante con osteoporosis, en donde el medicamento está indicado para suministrar desde 100 hasta 200 unidades de PTH(1-34)/semana.
MX2012003892A 2009-11-18 2010-11-05 Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante. MX339484B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26221409P 2009-11-18 2009-11-18
PCT/JP2010/069742 WO2011062073A1 (ja) 2009-11-18 2010-11-05 ヒト変形性膝関節症の予防剤および／または治療剤および／または増悪抑制剤

Publications (2)

Publication Number Publication Date
MX2012003892A MX2012003892A (es) 2012-05-08
MX339484B true MX339484B (es) 2016-05-27

Family

ID=44059554

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003892A MX339484B (es) 2009-11-18 2010-11-05 Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante.

Country Status (14)

Country Link
US (2) US20110172154A1 (es)
EP (1) EP2502632B1 (es)
JP (1) JP5969763B2 (es)
KR (1) KR101686271B1 (es)
CN (1) CN102686236A (es)
AU (1) AU2010320272B2 (es)
BR (1) BR112012002391A2 (es)
CA (1) CA2770340C (es)
ES (1) ES2616004T3 (es)
IL (1) IL217722B (es)
MX (1) MX339484B (es)
NZ (1) NZ598856A (es)
RU (1) RU2569754C2 (es)
WO (1) WO2011062073A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107635576A (zh) * 2015-07-07 2018-01-26 旭化成制药株式会社 特发性股骨头坏死症的发病预防和/或进展抑制剂
AU2017277747A1 (en) * 2016-06-10 2019-01-17 Regulaxis Peptides for the treatment of osteoarthritis
WO2018144719A1 (en) * 2017-02-01 2018-08-09 The Johns Hopkins University Parathyroid hormone and regeneration of degenerative discs disease

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140924A (en) 1980-04-04 1981-11-04 Teijin Ltd Calcitonin pharmaceutical preparation
GB2092002B (en) 1981-01-14 1985-09-11 Toyo Jozo Kk Suppositories injectable solutions
FR2509175B1 (fr) 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption
JPS60161924A (ja) 1984-02-01 1985-08-23 Fujisawa Pharmaceut Co Ltd 肺吸収用組成物
JPS63243033A (ja) 1987-03-31 1988-10-07 Toyo Jozo Co Ltd 経鼻投与組成物
JPS63316737A (ja) 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
JP2505812B2 (ja) 1987-07-10 1996-06-12 旭化成工業株式会社 ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
JPH02111A (ja) 1987-08-03 1990-01-05 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド製剤
JPH01230530A (ja) 1987-11-21 1989-09-14 Toyo Jozo Co Ltd カルシトニン類経鼻投与用液剤組成物
JPH02104531A (ja) 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
JP2006137768A (ja) 1993-10-27 2006-06-01 Chugai Pharmaceut Co Ltd 軟骨整復術治療促進剤
JPH07238033A (ja) 1993-10-27 1995-09-12 Chugai Pharmaceut Co Ltd 軟骨整復術治療促進剤
DE69637104T2 (de) * 1995-02-20 2008-01-31 Yukio Kato Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
JP3901761B2 (ja) * 1995-02-20 2007-04-04 幸夫 加藤 変形性関節症および炎症性関節疾患治療剤
US7087248B2 (en) 2000-06-30 2006-08-08 Daiichi Asubio Pharma Co., Ltd. Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component
US7521528B2 (en) * 2003-01-24 2009-04-21 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs with lactam bridges
WO2005102381A1 (ja) * 2004-04-26 2005-11-03 Ono Pharmaceutical Co., Ltd. カテプシンｋ阻害薬およびpth類を併用することを特徴とする骨密度増加剤
JP2006143603A (ja) * 2004-11-16 2006-06-08 Asahi Kasei Pharma Kk 骨疾患治療用医薬複合剤
US20090010940A1 (en) * 2005-09-06 2009-01-08 Paul Morley Parathyroid Hormone Analogues and Methods of Use
EP2349325B1 (en) * 2008-10-13 2018-05-30 University Of Rochester Teriparatide for use for promoting repair of articular cartilage
US8586533B2 (en) * 2008-12-16 2013-11-19 Kaohsiung Medical University Treatment of early-stage osteoarthritis
US8530420B2 (en) * 2008-12-16 2013-09-10 Kaohsiung Medical University Treatment of arthritis with parathyroid hormone
ES2663322T3 (es) * 2009-09-09 2018-04-12 Asahi Kasei Pharma Corporation Agente terapéutico/profiláctico que contiene PTH para la osteoporosis, caracterizado porque la PTH se administra una vez por semana en una dosis unitaria de 200 unidades

Also Published As

Publication number Publication date
JP5969763B2 (ja) 2016-08-17
US20130012440A1 (en) 2013-01-10
US20110172154A1 (en) 2011-07-14
ES2616004T3 (es) 2017-06-09
JPWO2011062073A1 (ja) 2013-04-04
CA2770340A1 (en) 2011-05-26
AU2010320272A1 (en) 2012-04-12
CA2770340C (en) 2019-08-27
WO2011062073A1 (ja) 2011-05-26
EP2502632A4 (en) 2013-04-03
CN102686236A (zh) 2012-09-19
KR20120116901A (ko) 2012-10-23
IL217722B (en) 2018-06-28
NZ598856A (en) 2013-10-25
IL217722A0 (en) 2012-03-29
AU2010320272B2 (en) 2015-01-22
MX2012003892A (es) 2012-05-08
RU2012125066A (ru) 2013-12-27
EP2502632B1 (en) 2016-12-28
RU2569754C2 (ru) 2015-11-27
EP2502632A1 (en) 2012-09-26
KR101686271B1 (ko) 2016-12-13
BR112012002391A2 (pt) 2016-06-07

Similar Documents

Publication Publication Date Title
UA106634C2 (uk) Тверда фармацевтична дозована форма
PH12016500606A1 (en) Insulin preparations containing methionine
UA114710C2 (uk) Похідне оксинтомодуліну та фармацевтична композиція для запобігання або лікування ожиріння, яка його містить
NZ603319A (en) Diabetes therapy
MX2013013809A (es) Dispositivos expandibles con revestimiento de una composicion de paclitaxel.
GB2491775A (en) Pulsatile drug release
PH12012502161A1 (en) Pharmaceutical formulations comprising pioglitazone and linagliptin
IN2014MN00933A (es)
MY191380A (en) Stabilized fixed dose drug composition having mometasone and olopatadine
NZ602510A (en) Treatment of lupus nephritis using laquinimod
JO3156B1 (ar) ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا
NZ598600A (en) Therapeutic agent for rhinitis
EP3513789A3 (en) Prophylactic and therapeutic agents for fgfr3 diseases
MX335951B (es) Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades.
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
EP2168586A4 (en) ACTIVE AGENT, REMEDY, PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF PATIENTS WITH DENTAL SYNDROME
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
MX339484B (es) Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante.
MX2013013808A (es) Dispositivos expandibles con revestimiento de una composicion de rapamicina.
GB2446341A (en) Method and system for transdermal drug delivery
IN2014CN04222A (es)
UA109944U (uk) Фармацевтична композиція для зниження рівня n-оксиду триметиламіну
MX2012002952A (es) Agente terapeutico para el dolor cronico.

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration